Key considerations for the use of artificial intelligence in healthcare and clinical research.

Christopher A Lovejoy¹, Anmol Arora², Varun Buch³, Ittai Dayan⁴

¹University College London, London, UK and University College Hospital, London, UK.

²University of Cambridge, Cambridge, UK and honorary research fellow, Moorfields Eye Hospital, London UK.

³MGH & BWH Center for Clinical Data Science, Boston, USA.

⁴Partners HealthCare, Boston, USA and chief executive officer, Rhino Health, Boston, USA.

PubMed PMC DOI PDF

Abstract

Interest in artificial intelligence (AI) has grown exponentially in recent years, attracting sensational headlines and speculation. While there is considerable potential for AI to augment clinical practice, there remain numerous practical implications that must be considered when exploring AI solutions. These range from ethical concerns about algorithmic bias to legislative concerns in an uncertai…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.